Pubblicazioni

Clinical and Prognostic Features of Essential Thrombocythemia: Comparison of 2001 WHO Versus 2008/2016 WHO Criteria in a Large Single-center Cohort

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Chiatamone Ranieri, S.; Arleo, M. A.; Trasarti, S.; Bizzoni, L.; Carmosino, I.; De Luca, M. L.; Mohamed, S.; Mariggio, E.; Scalzulli, E.; Rosati, S.; De Benedittis, D.; Colafigli, G.; Pepe, S.; Molica, M.; Scamuffa, M. C.; Di Prima, A.; Ferretti, A.; Baldacci, E.; Mancini, M.; Santoro, C.; Vignetti, M.; Breccia, M.; Latagliata, R.

IgD Subtype But Not IgM or Non-Secretory Is a Prognostic Marker for Poor Survival Following Autologous Hematopoietic Cell Transplantation in Multiple Myeloma. Results From the EBMT CALM (Collaboration to Collect Autologous Transplant Outcomes in Lymphomas and Myeloma) Study

2021 - CLINICAL LYMPHOMA MYELOMA & LEUKEMIA

Lawless, S; Sbianchi, G; Morris, C; Iacobelli, S; Bosman, P; Blaise, D; Remenyi, P; Byrne, Jl; Mayer, J; Apperley, J; Lund, J; Kobbe, G; Schaap, N; Isaksson, C; Lenhoff, S; Basak, G; Touzeau, C; Wilson, Kmo; Muniz, Sg; Scheid, C; Browne, P; Anagnostopoulos, A; Rambaldi, A; Jantunen, E; Kroger, N; Schonland, S; Yakoub-Agha, I; Garderet, L